ENDRA Life Sciences (NDRA) Net Income (2016 - 2026)

ENDRA Life Sciences (NDRA) has reported Net Income for 11 consecutive years, with -$1.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Income fell 26.55% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at -$7.3 million (up 18.37% YoY), while the FY2025 annual figure was -$5.6 million, up 48.05% from the prior year.
• Net Income rose to -$1.3 million in Q1 2026 per NDRA's latest filing, from -$3.2 million in the prior quarter.
• Across five years, Net Income topped out at -$1.0 million in Q1 2025 and bottomed at -$3.6 million in Q2 2022.
• Historically, Net Income has averaged -$2.5 million across 5 years, with a median of -$2.8 million in 2024.
• Annual changes were most pronounced in 2024 — Net Income sank 127.92% — and 2025, when it jumped 62.66%.
• ENDRA Life Sciences' Net Income stood at -$3.3 million in 2022, then soared by 55.63% to -$1.5 million in 2023, then tumbled by 127.92% to -$3.3 million in 2024, then climbed by 4.73% to -$3.2 million in 2025, then jumped by 58.62% to -$1.3 million in 2026.
• Business Quant data shows NDRA's Net Income at -$1.3 million in Q1 2026, -$3.2 million in Q4 2025, and -$1.6 million in Q3 2025.